Want to buy for someone else? You can purchase a token at check out.
Overview
The goal of this course is to provide nursing and pharmacy professionals with an overview of diabetes management in order to optimize patient-specific care.Goals and Learning Outcomes
Diabetes affects approximately 463 million people worldwide (International Diabetes Federation, 2020). Diabetes frequently presents together with other comorbidities and can result in life-threatening complications. Over the past several decades, the number of adults diagnosed with diabetes in the U.S. has increased drastically. In 2018, 34.2 million Americans had diabetes, and this number increases by approximately 1.5 million every year (Centers for Disease Control and Prevention [CDC], 2020). Unfortunately, according to the World Health Organization (WHO), rising numbers are now seen more in low to middle-income countries (WHO, 2021).
- Review the prevalence and economic burden of patients with diabetes
- Identify the different diabetes classifications
- Review the diagnostic criteria for diabetes
- List the goals associated with glycemic targets and blood pressure from updated guidelines for diabetes management
- Identify hypoglycemia risk, severity levels, and treatment options
- Review current nonpharmacological and pharmacological treatment options for diabetes
- Describe four diabetes classifications and discuss the diagnostic criteria for each type.
- Discuss hypoglycemia risk, severity levels, and treatment options.
- Identify current nonpharmacological and pharmacological treatment options for diabetes.
- Describe four diabetes classifications and discuss the diagnostic criteria for each type.
- Discuss hypoglycemia risk, severity levels, and treatment options.
- Identify current nonpharmacological and pharmacological treatment options for diabetes.
Course Details
Course Originally Released on : 4/1/2022
REL-ACU-0-CTMD
Course Author
BSN,RN
MPH, BCPS
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 1.00 CE contact hours for 06/13/2022 to 06/13/2023 (activity code: H00051012, approval number: 220001858).